US 7118738
Recombinant pox virus for immunization against MUC1 tumor-associated antigen
granted A61KA61K39/00
Quick answer
US patent 7118738 (Recombinant pox virus for immunization against MUC1 tumor-associated antigen) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K39/00